Efficacy of Apremilast in Patients With Moderate-to-Severe Plaque Psoriasis Across Weight and BMI Subgroups: Analysis From ESTEEM 1 and ESTEEM 2

Richard G. Langley, Nehal N. Mehta,Jeffrey Crowley,Cynthia Deignan,Sue Cheng,Mindy Chen, Weiling Wang,Bruce Strober

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2023）

引用 0|浏览8

暂无评分

摘要

Background: Obesity is prevalent in psoriasis patients and may interfere with treatment efficacy. Apremilast is an oral immunomodulator of phosphodiesterase 4 indicated for psoriasis treatment.

查看译文

关键词

psoriasis,apremilast,bmi subgroups,plaque,moderate-to-severe

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要